Form 4 for CVS CVS Health
Accepted 2023-04-04 00:00:00 ET · period of report 2023-04-01 · accession 0001127602-23-012216 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-04-04 | 2023-04-01 | CVS | Clark James David | SVP, Cont, Chief Acct Off | A - Grant | $74.31 | +2,186 | 9,080 | +32% | +$162.4K |
| D | 2023-04-04 | 2023-04-01 | CVS | Clark James David | SVP, Cont, Chief Acct Off | F - Tax | $74.31 | -1,471 | 30.5K | -5% | -$109.3K |
| D | 2023-04-04 | 2023-04-01 | CVS | Clark James David | SVP, Cont, Chief Acct Off | A - Grant | $74.31 | +9,649 | 9,649 | New | +$717.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock (Restricted) | 2023-04-01 | A | A | 2,186 | $74.31 | 9,080 | D | — | — | (F2) Consists of restricted stock units awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse in four equal installments, commencing 4/1/2024. |
| 2 | Common | Common Stock | 2023-04-01 | F | D | 1,471 | $74.31 | 30,457.26 | D | — | — | (F1) Surrender of shares in payment of withholding taxes due upon the vesting and settlement of a restricted stock unit award. |
| 3 | Derivative | Stock Option | 2023-04-01 | A | A | 9,649 | $74.31 | 9,649 | D | $74.31 · 2024-04-01 to 2033-04-01 | 9,649 Common Stock | (F11) Option becomes exercisable in four equal annual installments, commencing 4/1/2024. |